Viridian Therapeutics, Inc. (VRDN) Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease Transcript

Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease June 29, 2026 8:00 ...